2022 Q1 Form 10-Q Financial Statement

#000156459022017840 Filed on May 04, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1 2020 Q4
Revenue $199.0M $98.12M $88.90M
YoY Change 102.8% 17.63% 20.31%
Cost Of Revenue $108.3M $90.06M $92.40M
YoY Change 20.2% 11.37% 7.19%
Gross Profit $90.73M $8.060M -$3.465M
YoY Change 1025.68% 215.95% -71.78%
Gross Profit Margin 45.6% 8.21% -3.9%
Selling, General & Admin $10.94M $8.793M $6.500M
YoY Change 24.36% -12.12% -31.58%
% of Gross Profit 12.05% 109.09%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $17.20M $16.76M $17.93M
YoY Change 2.6% -4.72% 5.1%
% of Gross Profit 18.95% 207.97%
Operating Expenses $10.94M $8.793M $6.700M
YoY Change 24.36% -12.12% -64.74%
Operating Profit $79.97M -$470.0K -$10.16M
YoY Change -17115.11% -93.27% -67.5%
Interest Expense $9.955M $12.37M $80.00K
YoY Change -19.54% 832.33% -100.66%
% of Operating Profit 12.45%
Other Income/Expense, Net -$135.0K -$395.0K -$600.0K
YoY Change -65.82% -158.52% -220.0%
Pretax Income $69.88M -$13.24M -$23.40M
YoY Change -627.92% -33.15% -45.33%
Income Tax $11.10M $42.00K -$1.741M
% Of Pretax Income 15.88%
Net Earnings $58.77M -$13.28M -$21.69M
YoY Change -542.55% -31.73% -21.73%
Net Earnings / Revenue 29.53% -13.53% -24.4%
Basic Earnings Per Share $0.66 -$0.63
Diluted Earnings Per Share $0.65 -$0.63 -$769.5K
COMMON SHARES
Basic Shares Outstanding 88.42M 36.85M
Diluted Shares Outstanding 89.77M 36.85M

Balance Sheet

Concept 2022 Q1 2021 Q1 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $343.6M $14.20M $16.30M
YoY Change 2319.79% -62.13% -28.51%
Cash & Equivalents $254.3M $14.23M $16.26M
Short-Term Investments $89.31M
Other Short-Term Assets $61.37M $45.40M $51.20M
YoY Change 35.18% 6.32% 14.29%
Inventory $27.40M $19.20M $19.57M
Prepaid Expenses
Receivables $97.05M $60.10M $42.55M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $529.4M $139.0M $129.6M
YoY Change 280.89% -11.6% -0.99%
LONG-TERM ASSETS
Property, Plant & Equipment $875.2M $910.5M $891.2M
YoY Change -3.88% -1.93% -4.83%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $32.52M
YoY Change 53.84%
Total Long-Term Assets $878.8M $916.0M $923.7M
YoY Change -4.07% -3.87% -3.54%
TOTAL ASSETS
Total Short-Term Assets $529.4M $139.0M $129.6M
Total Long-Term Assets $878.8M $916.0M $923.7M
Total Assets $1.408B $1.055B $1.053B
YoY Change 33.48% -4.97% -3.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $60.65M $57.40M $46.55M
YoY Change 5.66% 6.28% -20.39%
Accrued Expenses $44.91M $39.30M $28.50M
YoY Change 14.28% 5.08% 35.07%
Deferred Revenue
YoY Change
Short-Term Debt $9.911M $8.200M $13.58M
YoY Change 20.87% 18.96% 36.73%
Long-Term Debt Due $8.112M $18.08M $16.80M
YoY Change -55.14% 87.09% 78.54%
Total Short-Term Liabilities $123.6M $124.3M $107.3M
YoY Change -0.58% 11.87% 3.87%
LONG-TERM LIABILITIES
Long-Term Debt $708.4M $463.7M $467.4M
YoY Change 52.78% -3.57% 3.95%
Other Long-Term Liabilities $20.57M $26.60M $25.90M
YoY Change -22.69% 35.03% 47.16%
Total Long-Term Liabilities $708.4M $463.7M $467.4M
YoY Change 52.78% -3.57% 3.95%
TOTAL LIABILITIES
Total Short-Term Liabilities $123.6M $124.3M $107.3M
Total Long-Term Liabilities $708.4M $463.7M $467.4M
Total Liabilities $890.0M $645.8M $574.7M
YoY Change 37.81% 9.1% 3.93%
SHAREHOLDERS EQUITY
Retained Earnings -$41.49M
YoY Change -171.99%
Common Stock $3.128M
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $13.21M
YoY Change -0.4%
Treasury Stock Shares
Shareholders Equity $518.2M $127.0M $149.6M
YoY Change
Total Liabilities & Shareholders Equity $1.408B $1.055B $1.053B
YoY Change 33.48% -4.97% -3.23%

Cashflow Statement

Concept 2022 Q1 2021 Q1 2020 Q4
OPERATING ACTIVITIES
Net Income $58.77M -$13.28M -$21.69M
YoY Change -542.55% -31.73% -21.73%
Depreciation, Depletion And Amortization $17.20M $16.76M $17.93M
YoY Change 2.6% -4.72% 5.1%
Cash From Operating Activities $85.49M $12.71M -$27.23M
YoY Change 572.58% -683.61% -29.95%
INVESTING ACTIVITIES
Capital Expenditures $8.254M $6.133M -$8.240M
YoY Change 34.58% -42.88% -47.25%
Acquisitions
YoY Change
Other Investing Activities -$51.00K -$198.0K $40.00K
YoY Change -74.24% 10.61% -33.33%
Cash From Investing Activities -$97.51M -$5.935M -$8.210M
YoY Change 1543.03% -43.79% -47.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 184.2M -8.808M 9.600M
YoY Change -2191.02% -132.11% -8.13%
NET CHANGE
Cash From Operating Activities 85.49M 12.71M -27.23M
Cash From Investing Activities -97.51M -5.935M -8.210M
Cash From Financing Activities 184.2M -8.808M 9.600M
Net Change In Cash 172.2M -2.032M -25.84M
YoY Change -8572.19% -113.83% -41.26%
FREE CASH FLOW
Cash From Operating Activities $85.49M $12.71M -$27.23M
Capital Expenditures $8.254M $6.133M -$8.240M
Free Cash Flow $77.24M $6.578M -$18.99M
YoY Change 1074.19% -150.93% -18.32%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P33M
CY2022Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P2Y
CY2022Q1 lxu Related Party Commitment Obligation Percentage
RelatedPartyCommitmentObligationPercentage
0.50
CY2022Q1 lxu Number Of Settlement Agreements
NumberOfSettlementAgreements
3
CY2022Q1 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent
CY2021Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent
CY2021Q4 lxu Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
33301000
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
108251000
CY2021Q1 us-gaap Cost Of Revenue
CostOfRevenue
90056000
CY2022Q1 us-gaap Gross Profit
GrossProfit
90730000
CY2021Q1 us-gaap Gross Profit
GrossProfit
8060000
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10935000
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8793000
CY2022Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
176000
CY2021Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
263000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
79971000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-470000
CY2022Q1 us-gaap Interest Expense
InterestExpense
9955000
CY2021Q1 us-gaap Interest Expense
InterestExpense
12372000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-135000
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-395000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
460490000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
58766000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
803000
CY2022Q1 lxu Stock Issued During Period Value Other Net
StockIssuedDuringPeriodValueOtherNet
-1871000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
518188000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
149643000
CY2021Q1 us-gaap Temporary Equity Accretion Of Dividends
TemporaryEquityAccretionOfDividends
9511000
CY2021Q1 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
511000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
713000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
69881000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13237000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11115000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
42000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
58766000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-13279000
CY2021Q1 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
75000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
58766000
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-23376000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.66
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.63
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.65
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.63
CY2021Q1 lxu Stock Issued During Period Value Other Net
StockIssuedDuringPeriodValueOtherNet
-18000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
127037000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
58766000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-13279000
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
10823000
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
327000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
17197000
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16762000
CY2022Q1 lxu Amortization Of Intangible And Other Assets
AmortizationOfIntangibleAndOtherAssets
311000
CY2021Q1 lxu Amortization Of Intangible And Other Assets
AmortizationOfIntangibleAndOtherAssets
315000
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1438000
CY2021Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
1058000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
11707000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
17321000
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
10817000
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-625000
CY2022Q1 us-gaap Increase Decrease In Prepaid Insurance
IncreaseDecreaseInPrepaidInsurance
-3687000
CY2021Q1 us-gaap Increase Decrease In Prepaid Insurance
IncreaseDecreaseInPrepaidInsurance
-2265000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
10003000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
8598000
CY2022Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
13618000
CY2021Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
10412000
CY2022Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-7827000
CY2021Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
5065000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
85492000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
12711000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8254000
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6133000
CY2022Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
89311000
CY2022Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-51000
CY2021Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-198000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-97514000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5935000
CY2022Q1 us-gaap Proceeds From Secured Notes Payable
ProceedsFromSecuredNotesPayable
200000000
CY2022Q1 us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
6912000
CY2021Q1 us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
3353000
CY2022Q1 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
2805000
CY2021Q1 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
5419000
CY2022Q1 lxu Payments Of Debt Related Costs
PaymentsOfDebtRelatedCosts
4102000
CY2022Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-2004000
CY2021Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-36000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
184177000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-8808000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
172155000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2032000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
82144000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16264000
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
254299000
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14232000
CY2022Q1 lxu Number Of Facilities For Manufacture And Distribution Of Products
NumberOfFacilitiesForManufactureAndDistributionOfProducts
4
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates<span style="font-weight:normal;"> </span>–<span style="font-weight:normal;"> The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. </span></p>
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-23376000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
88421000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36850000
CY2022Q1 lxu Unvested Restricted Stock And Stock Units
UnvestedRestrictedStockAndStockUnits
1345000
CY2022Q1 lxu Dilutive Potential Common Shares1
DilutivePotentialCommonShares1
1345000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
89766000
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
36850000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.66
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.63
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.65
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
58766000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-13279000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
58766000
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.63
CY2021Q4 lxu Accrued And Other Liabilities Noncurrent
AccruedAndOtherLiabilitiesNoncurrent
3030000
CY2022Q1 lxu Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
44913000
CY2021Q4 lxu Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
33301000
CY2022Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
13944000
CY2021Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
9722000
CY2022Q1 us-gaap Long Term Debt
LongTermDebt
716510000
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13000
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3850851
CY2022Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
22015000
CY2021Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
8397000
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7293000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7755000
CY2022Q1 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
6582000
CY2021Q4 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
9794000
CY2022Q1 lxu Accrued Death And Other Executive Benefits
AccruedDeathAndOtherExecutiveBenefits
2508000
CY2021Q4 lxu Accrued Death And Other Executive Benefits
AccruedDeathAndOtherExecutiveBenefits
2514000
CY2022Q1 lxu Accrued Health And Worker Compensation Insurance Claims
AccruedHealthAndWorkerCompensationInsuranceClaims
1103000
CY2021Q4 lxu Accrued Health And Worker Compensation Insurance Claims
AccruedHealthAndWorkerCompensationInsuranceClaims
1272000
CY2022Q1 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
8435000
CY2021Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
6599000
CY2022Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
47936000
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
36331000
CY2022Q1 lxu Accrued And Other Liabilities Noncurrent
AccruedAndOtherLiabilitiesNoncurrent
3023000
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
527644000
CY2022Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
8112000
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
9454000
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
708398000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
518190000
CY2021Q1 lxu Realized Gain Loss On Natural Gas Forward Contracts Held
RealizedGainLossOnNaturalGasForwardContractsHeld
6800000
CY2022Q1 lxu Liability Reserve
LiabilityReserve
0
CY2021Q4 lxu Liability Reserve
LiabilityReserve
0
CY2021Q1 lxu Gain Loss On Sale Natural Gas Forward Contracts
GainLossOnSaleNaturalGasForwardContracts
2700000
CY2022Q1 lxu Unrealized Gain Loss On Natural Gas Forward Contracts Held
UnrealizedGainLossOnNaturalGasForwardContractsHeld
0
CY2022Q1 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
292000
CY2021Q1 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-285000
CY2022Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
292000
CY2021Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-285000
CY2022Q1 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
11385000
CY2021Q1 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-80000
CY2022Q1 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-562000
CY2021Q1 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
407000
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
10823000
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
327000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11115000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
42000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11100000
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.159
CY2022Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Explanation
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation
contracts have an original expected duration of one year or less, for our contracts with a duration greater than one year at contract inception, the average remaining expected duration was approximately 17 months
CY2022Q1 lxu Weighted Average Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period
WeightedAverageRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod
P17M
CY2022Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1800000
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1600000
CY2022Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1400000
CY2021Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1000000.0
CY2022Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
74000000
CY2022Q1 lxu Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Percent
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPercent
0.37
CY2022Q1 lxu Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Percent
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPercent
0.30
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-216000
CY2022Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
17295000
CY2021Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
18091000
CY2022Q1 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
741000

Files In Submission

Name View Source Status
0001564590-22-017840-index-headers.html Edgar Link pending
0001564590-22-017840-index.html Edgar Link pending
0001564590-22-017840.txt Edgar Link pending
0001564590-22-017840-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
lxu-10q_20220331.htm Edgar Link pending
lxu-10q_20220331_htm.xml Edgar Link completed
lxu-20220331.xsd Edgar Link pending
lxu-20220331_cal.xml Edgar Link unprocessable
lxu-20220331_def.xml Edgar Link unprocessable
lxu-20220331_lab.xml Edgar Link unprocessable
lxu-20220331_pre.xml Edgar Link unprocessable
lxu-ex311_9.htm Edgar Link pending
lxu-ex312_6.htm Edgar Link pending
lxu-ex321_7.htm Edgar Link pending
lxu-ex322_8.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending